Latest news with #Straumann
Yahoo
28-06-2025
- Business
- Yahoo
A Look At The Fair Value Of Straumann Holding AG (VTX:STMN)
Using the 2 Stage Free Cash Flow to Equity, Straumann Holding fair value estimate is CHF87.37 Straumann Holding's CHF105 share price indicates it is trading at similar levels as its fair value estimate The CHF126 analyst price target for STMN is 44% more than our estimate of fair value Today we will run through one way of estimating the intrinsic value of Straumann Holding AG (VTX:STMN) by taking the expected future cash flows and discounting them to their present value. One way to achieve this is by employing the Discounted Cash Flow (DCF) model. There's really not all that much to it, even though it might appear quite complex. We would caution that there are many ways of valuing a company and, like the DCF, each technique has advantages and disadvantages in certain scenarios. If you still have some burning questions about this type of valuation, take a look at the Simply Wall St analysis model. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. We're using the 2-stage growth model, which simply means we take in account two stages of company's growth. In the initial period the company may have a higher growth rate and the second stage is usually assumed to have a stable growth rate. To start off with, we need to estimate the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years. Generally we assume that a dollar today is more valuable than a dollar in the future, so we discount the value of these future cash flows to their estimated value in today's dollars: 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 Levered FCF (CHF, Millions) CHF478.9m CHF540.7m CHF598.3m CHF534.4m CHF592.6m CHF600.1m CHF606.1m CHF611.1m CHF615.5m CHF619.3m Growth Rate Estimate Source Analyst x8 Analyst x9 Analyst x7 Analyst x1 Analyst x1 Est @ 1.26% Est @ 1.01% Est @ 0.83% Est @ 0.71% Est @ 0.62% Present Value (CHF, Millions) Discounted @ 4.6% CHF458 CHF494 CHF522 CHF446 CHF473 CHF457 CHF442 CHF426 CHF410 CHF394 ("Est" = FCF growth rate estimated by Simply Wall St)Present Value of 10-year Cash Flow (PVCF) = CHF4.5b The second stage is also known as Terminal Value, this is the business's cash flow after the first stage. For a number of reasons a very conservative growth rate is used that cannot exceed that of a country's GDP growth. In this case we have used the 5-year average of the 10-year government bond yield (0.4%) to estimate future growth. In the same way as with the 10-year 'growth' period, we discount future cash flows to today's value, using a cost of equity of 4.6%. Terminal Value (TV)= FCF2034 × (1 + g) ÷ (r – g) = CHF619m× (1 + 0.4%) ÷ (4.6%– 0.4%) = CHF15b Present Value of Terminal Value (PVTV)= TV / (1 + r)10= CHF15b÷ ( 1 + 4.6%)10= CHF9.4b The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is CHF14b. In the final step we divide the equity value by the number of shares outstanding. Compared to the current share price of CHF105, the company appears around fair value at the time of writing. Remember though, that this is just an approximate valuation, and like any complex formula - garbage in, garbage out. We would point out that the most important inputs to a discounted cash flow are the discount rate and of course the actual cash flows. If you don't agree with these result, have a go at the calculation yourself and play with the assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Straumann Holding as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 4.6%, which is based on a levered beta of 0.971. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business. See our latest analysis for Straumann Holding Strength Debt is not viewed as a risk. Weakness Earnings growth over the past year underperformed the Medical Equipment industry. Dividend is low compared to the top 25% of dividend payers in the Medical Equipment market. Opportunity Annual earnings are forecast to grow faster than the Swiss market. Good value based on P/E ratio compared to estimated Fair P/E ratio. Threat Revenue is forecast to grow slower than 20% per year. Valuation is only one side of the coin in terms of building your investment thesis, and it shouldn't be the only metric you look at when researching a company. The DCF model is not a perfect stock valuation tool. Rather it should be seen as a guide to "what assumptions need to be true for this stock to be under/overvalued?" For example, changes in the company's cost of equity or the risk free rate can significantly impact the valuation. For Straumann Holding, we've put together three fundamental factors you should consider: Financial Health: Does STMN have a healthy balance sheet? Take a look at our free balance sheet analysis with six simple checks on key factors like leverage and risk. Future Earnings: How does STMN's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart. Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered! PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the SWX every day. If you want to find the calculation for other stocks just search here. — Investing narratives with Fair Values A case for TSXV:USA to reach USD $5.00 - $9.00 (CAD $7.30–$12.29) by 2029. By Agricola – Community Contributor Fair Value Estimated: CA$12.29 · 0.9% Overvalued DLocal's Future Growth Fueled by 35% Revenue and Profit Margin Boosts By WynnLevi – Community Contributor Fair Value Estimated: $195.39 · 0.9% Overvalued Historically Cheap, but the Margin of Safety Is Still Thin By Mandelman – Community Contributor Fair Value Estimated: SEK232.58 · 0.1% Overvalued View more featured narratives — Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. 擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤
Yahoo
17-06-2025
- Business
- Yahoo
Dental Prosthetics Market Report 2025: Global Analysis, Size, Share, Trends, and Forecast to 2032 - 3D Printing and CAD/CAM Revolutionizing Production, Rising Demand for Aesthetic Dentistry
The global dental prosthetics market, driven by tech innovations and rising demand for aesthetic solutions, is projected to grow from $4.18B in 2025 to $7.43B by 2032. Key growth factors include an aging population and advances in digital dentistry. Major players like Dentsply Sirona and Straumann lead the market. Dublin, June 17, 2025 (GLOBE NEWSWIRE) -- The "Dental Prosthetics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)" report has been added to offering. The global dental prosthetics market is undergoing a profound transformation, fueled by technological advancements, an aging population, and the growing demand for cosmetic dentistry. As dental healthcare continues to evolve, the market is witnessing a strong surge in demand for advanced, durable, and aesthetically appealing prosthetic solutions. According to recent industry forecasts, the dental prosthetics market is expected to expand from an estimated US$ 4.18 Bn in 2025 to US$ 7.43 Bn by 2032, growing at a remarkable CAGR of 8.56% during the forecast InsightsDental prosthetics are artificial replacements used to restore missing teeth and surrounding oral structures. These solutions play a vital role in restoring oral function, enhancing aesthetics, and improving the quality of life for patients affected by tooth loss, decay, or injury. The market encompasses a variety of products, including dentures, crowns, bridges, and abutments. As patients increasingly seek long-lasting, custom-tailored prosthetics, the market is adapting to meet rising technologies like 3D printing and CAD/CAM systems have revolutionized the design and manufacturing process of dental prosthetics. These innovations allow for greater precision, faster turnaround times, and personalized treatments, enhancing both provider efficiency and patient DriversOne of the primary factors driving market growth is the rising demand for aesthetic and restorative dental treatments. As global populations become more image-conscious and oral health awareness increases, patients are increasingly opting for solutions such as crowns, veneers, and implant-supported dentures. The growth in cosmetic dentistry is particularly pronounced among younger demographics and working professionals, who prioritize appearance alongside the growing elderly population significantly contributes to market expansion. Older individuals are more susceptible to dental issues, including tooth loss, gum disease, and oral infections. This demographic shift is prompting increased demand for prosthetics like full and partial dentures, crowns, and bridges to restore oral function and advancements, especially in digital dentistry, are also propelling market growth. Computer-Aided Design and Computer-Aided Manufacturing (CAD/CAM) technologies allow for the rapid creation of customized prosthetics, enhancing accuracy while minimizing human error. These systems are now widely adopted across dental clinics and laboratories globally, streamlining operations and improving clinical OpportunityThe integration of digital dentistry and 3D printing offers transformative opportunities for stakeholders across the value chain. These technologies allow for cost-effective production and customization of prosthetics, reducing labor time and improving scalability. The opportunity for mass personalization - providing unique prosthetics tailored to individual patients - positions digital workflows as a game-changer in the promising opportunity lies in the development of new materials. Advanced biocompatible and aesthetic materials such as zirconia and ceramics are gaining popularity due to their durability, safety, and natural appearance. These materials enhance patient comfort while meeting the growing preference for minimally invasive, long-lasting, and visually appealing dental the growing dental tourism sector presents a lucrative opportunity for emerging markets. Many patients from developed countries are traveling abroad for affordable and high-quality dental treatments, creating new avenues for market growth in regions such as Asia-Pacific and Latin AnalysisNorth America continues to dominate the dental prosthetics market, accounting for a significant portion of global revenue. The region's dominance can be attributed to the high prevalence of dental diseases, well-established healthcare infrastructure, and rapid adoption of digital technologies. The presence of leading market players and regulatory frameworks that ensure product quality and safety further bolster North America's market remains a strong contributor, driven by the continuous innovation from dental technology firms that focus on developing cutting-edge materials and production techniques. With increasing investments in R&D and expanding access to digital dentistry, European markets are witnessing consistent Asia-Pacific region is expected to register the fastest growth during the forecast period. Rising disposable incomes, increased awareness of oral health, and an expanding base of dental professionals are key drivers in this region. Government initiatives to improve healthcare infrastructure and the rapid adoption of dental technologies are likely to further accelerate growth in countries such as China, India, and South PlayersThe competitive Analysis of the dental prosthetics market is highly fragmented, with several major players and numerous regional manufacturers striving for market share. Leading companies include: Dentsply Sirona Straumann Group Zimmer Biomet Nobel Biocare Ivoclar Vivadent VITA Zahnfabrik H. Rauter GmbH & Co. KG Merz Dental GmbH Polident D.O.O. Amt Medical SRL 3D Diagnostix Inc. Medical Precision Implants FSM Dental Medikal Mak. San. Tic. Ltd. Yamahachi Dental Mfg Co. These companies are focusing on continuous innovation, strategic mergers, and collaborations with dental clinics and laboratories to maintain competitiveness. Product differentiation, digital integration, and material innovation remain at the forefront of their DevelopmentsIn September 2023, Boston Micro Fabrication (BMF) launched the UltraThineer cosmetic dental veneer, marking its entry into the dental prosthetics space with advanced microfabrication November 2023, Whites Beaconsfield introduced non-peroxide, natural teeth whitening products specifically designed for dental veneers, addressing the growing consumer demand for safe, effective cosmetic dental Facing the MarketDespite the positive outlook, the dental prosthetics market faces challenges. High treatment costs and limited insurance coverage often prevent patients from accessing advanced prosthetic solutions. In developing regions, inadequate healthcare infrastructure and a shortage of trained professionals further restrict market remains a critical barrier, particularly for implant-supported prosthetics and custom-designed devices. Until these issues are addressed through better insurance coverage, cost-efficient solutions, or public healthcare support, the market will struggle to achieve widespread adoption in certain Prosthetics Market SegmentationBy Type Dentures Bridges Crowns Abutments By End Use Solo Practices DSO Practices By Region North America Latin America Europe Asia Pacific The Middle East & Africa Key Topics Covered: 1. Executive Summary1.1. Global Dental Prosthetics Market Snapshot1.2. Future Projections1.3. Key Market Trends1.4. Regional Snapshot, by Value, 20251.5. Analyst Recommendations2. Market Overview2.1. Market Definitions and Segmentations2.2. Market Dynamics2.2.1. Drivers2.2.2. Restraints2.2.3. Market Opportunities2.3. Value Chain Analysis2.4. Porter's Five Forces Analysis2.5. COVID-19 Impact Analysis2.5.1. Supply2.5.2. Demand2.6. PESTLE Analysis3. Global Dental Prosthetics Market Outlook, 2019-20323.1. Global Dental Prosthetics Market Outlook, by Type, Value (US$ Bn), 2019-20323.1.1. Key Highlights3.1.1.1. Dentures3.1.1.2. Bridges3.1.1.3. Crowns3.1.1.4. Abutments3.2. Global Dental Prosthetics Market Outlook, by End Use, Value (US$ Bn), 2019-20323.2.1. Key Highlights3.2.1.1. DSO Practices3.2.1.2. Solo Practices3.3. Global Dental Prosthetics Market Outlook, by Region, Value (US$ Bn), 2019-20323.3.1. Key Highlights3.3.1.1. North America3.3.1.2. Europe3.3.1.3. Asia Pacific3.3.1.4. Latin America3.3.1.5. Middle East & Africa4. North America Dental Prosthetics Market Outlook, 2019-20324.1. North America Dental Prosthetics Market Outlook, by Type, Value (US$ Bn), 2019-20324.1.1. Key Highlights4.1.1.1. Dentures4.1.1.2. Bridges4.1.1.3. Crowns4.1.1.4. Abutments4.2. North America Dental Prosthetics Market Outlook, by End Use, Value (US$ Bn), 2019-20324.2.1. Key Highlights4.2.1.1. DSO Practices4.2.1.2. Solo Practices4.3. North America Dental Prosthetics Market Outlook, by Country, Value (US$ Bn), 2019-20324.3.1. Key Highlights4.3.1.1. U.S. Dental Prosthetics Market by Type, Value (US$ Bn), 2019-20324.3.1.2. U.S. Dental Prosthetics Market by End Use, Value (US$ Bn), 2019-20324.3.1.3. Canada Dental Prosthetics Market by Type, Value (US$ Bn), 2019-20324.3.1.4. Canada Dental Prosthetics Market by End Use, Value (US$ Bn), 2019-20324.3.2. Market Attractiveness Analysis5. Europe Dental Prosthetics Market Outlook, 2019-20325.1. Europe Dental Prosthetics Market Outlook, by Type, Value (US$ Bn), 2019-20325.1.1. Key Highlights5.1.1.1. Dentures5.1.1.2. Bridges5.1.1.3. Crowns5.1.1.4. Abutments5.2. Europe Dental Prosthetics Market Outlook, by End Use, Value (US$ Bn), 2019-20325.2.1. Key Highlights5.2.1.1. DSO Practices5.2.1.2. Solo Practices5.3. Europe Dental Prosthetics Market Outlook, by Country, Value (US$ Bn), 2019-20325.3.1. Key Highlights5.3.1.1. Germany Dental Prosthetics Market by Type, Value (US$ Bn), 2019-20325.3.1.2. Germany Dental Prosthetics Market by End Use, Value (US$ Bn), 2019-20325.3.1.3. U.K. Dental Prosthetics Market by Type, Value (US$ Bn), 2019-20325.3.1.4. U.K. Dental Prosthetics Market by End Use, Value (US$ Bn), 2019-20325.3.1.5. France Dental Prosthetics Market by Type, Value (US$ Bn), 2019-20325.3.1.6. France Dental Prosthetics Market by End Use, Value (US$ Bn), 2019-20325.3.1.7. Italy Dental Prosthetics Market by Type, Value (US$ Bn), 2019-20325.3.1.8. Italy Dental Prosthetics Market by End Use, Value (US$ Bn), 2019-20325.3.1.9. Turkey Dental Prosthetics Market by Type, Value (US$ Bn), 2019-20325.3.1.10. Turkey Dental Prosthetics Market by End Use, Value (US$ Bn), 2019-20325.3.1.11. Russia Dental Prosthetics Market by Type, Value (US$ Bn), 2019-20325.3.1.12. Russia Dental Prosthetics Market by End Use, Value (US$ Bn), 2019-20325.3.1.13. Rest of Europe Dental Prosthetics Market by Type, Value (US$ Bn), 2019-20325.3.1.14. Rest of Europe Dental Prosthetics Market by End Use, Value (US$ Bn), 2019-20325.3.2. Market Attractiveness Analysis6. Asia Pacific Dental Prosthetics Market Outlook, 2019-20326.1. Asia Pacific Dental Prosthetics Market Outlook, by Type, Value (US$ Bn), 2019-20326.1.1. Key Highlights6.1.1.1. Dentures6.1.1.2. Bridges6.1.1.3. Crowns6.1.1.4. Abutments6.2. Asia Pacific Dental Prosthetics Market Outlook, by End Use, Value (US$ Bn), 2019-20326.2.1. Key Highlights6.2.1.1. DSO Practices6.2.1.2. Solo Practices6.2.2. Market Attractiveness Analysis6.3. Asia Pacific Dental Prosthetics Market Outlook, by Country, Value (US$ Bn), 2019-20326.3.1. Key Highlights6.3.1.1. China Dental Prosthetics Market by Type, Value (US$ Bn), 2019-20326.3.1.2. China Dental Prosthetics Market by End Use, Value (US$ Bn), 2019-20326.3.1.3. Japan Dental Prosthetics Market by Type, Value (US$ Bn), 2019-20326.3.1.4. Japan Dental Prosthetics Market by End Use, Value (US$ Bn), 2019-20326.3.1.5. South Korea Dental Prosthetics Market by Type, Value (US$ Bn), 2019-20326.3.1.6. South Korea Dental Prosthetics Market by End Use, Value (US$ Bn), 2019-20326.3.1.7. India Dental Prosthetics Market by Type, Value (US$ Bn), 2019-20326.3.1.8. India Dental Prosthetics Market by End Use, Value (US$ Bn), 2019-20326.3.1.9. Southeast Asia Dental Prosthetics Market by Type, Value (US$ Bn), 2019-20326.3.1.10. Southeast Asia Dental Prosthetics Market by End Use, Value (US$ Bn), 2019-20326.3.1.11. Rest of Asia Pacific Dental Prosthetics Market by Type, Value (US$ Bn), 2019-20326.3.1.12. Rest of Asia Pacific Dental Prosthetics Market by End Use, Value (US$ Bn), 2019-20326.3.2. Market Attractiveness Analysis7. Latin America Dental Prosthetics Market Outlook, 2019-20327.1. Latin America Dental Prosthetics Market Outlook, by Type, Value (US$ Bn), 2019-20327.1.1. Key Highlights7.1.1.1. Dentures7.1.1.2. Bridges7.1.1.3. Crowns7.1.1.4. Abutments7.2. Latin America Dental Prosthetics Market Outlook, by End Use, Value (US$ Bn), 2019-20327.2.1.1. DSO Practices7.2.1.2. Solo Practices7.2.2. Market Attractiveness Analysis7.3. Latin America Dental Prosthetics Market Outlook, by Country, Value (US$ Bn), 2019-20327.3.1. Key Highlights7.3.1.1. Brazil Dental Prosthetics Market by Type, Value (US$ Bn), 2019-20327.3.1.2. Brazil Dental Prosthetics Market by End Use, Value (US$ Bn), 2019-20327.3.1.3. Mexico Dental Prosthetics Market by Type, Value (US$ Bn), 2019-20327.3.1.4. Mexico Dental Prosthetics Market by End Use, Value (US$ Bn), 2019-20327.3.1.5. Argentina Dental Prosthetics Market by Type, Value (US$ Bn), 2019-20327.3.1.6. Argentina Dental Prosthetics Market by End Use, Value (US$ Bn), 2019-20327.3.1.7. Rest of Latin America Dental Prosthetics Market by Type, Value (US$ Bn), 2019-20327.3.1.8. Rest of Latin America Dental Prosthetics Market by End Use, Value (US$ Bn), 2019-20327.3.2. Market Attractiveness Analysis8. Middle East & Africa Dental Prosthetics Market Outlook, 2019-20328.1. Middle East & Africa Dental Prosthetics Market Outlook, by Type, Value (US$ Bn), 2019-20328.1.1. Key Highlights8.1.1.1. Dentures8.1.1.2. Bridges8.1.1.3. Crowns8.1.1.4. Abutments8.2. Middle East & Africa Dental Prosthetics Market Outlook, by End Use, Value (US$ Bn), 2019-20328.2.1. Key Highlights8.2.1.1. DSO Practices8.2.1.2. Solo Practices8.2.2. Market Attractiveness Analysis8.3. Middle East & Africa Dental Prosthetics Market Outlook, by Country, Value (US$ Bn), 2019-20328.3.1. Key Highlights8.3.1.1. GCC Dental Prosthetics Market by Type, Value (US$ Bn), 2019-20328.3.1.2. GCC Dental Prosthetics Market by End Use, Value (US$ Bn), 2019-20328.3.1.3. South Africa Dental Prosthetics Market by Type, Value (US$ Bn), 2019-20328.3.1.4. South Africa Dental Prosthetics Market by End Use, Value (US$ Bn), 2019-20328.3.1.5. Egypt Dental Prosthetics Market by Type, Value (US$ Bn), 2019-20328.3.1.6. Egypt Dental Prosthetics Market by End Use, Value (US$ Bn), 2019-20328.3.1.7. Nigeria Dental Prosthetics Market by Type, Value (US$ Bn), 2019-20328.3.1.8. Nigeria Dental Prosthetics Market by End Use, Value (US$ Bn), 2019-20328.3.1.9. Rest of Middle East & Africa Dental Prosthetics Market by Type, Value (US$ Bn), 2019-20328.3.1.10. Rest of Middle East & Africa Dental Prosthetics Market by End Use, Value (US$ Bn), 2019-20328.3.2. Market Attractiveness Analysis9. Competitive Landscape9.1. Company Market Share Analysis, 20259.2. Competitive Dashboard9.3. Company Profiles9.3.1. Polident D.O.O.9.3.1.1. Company Overview9.3.1.2. Therapy Portfolio9.3.1.3. Financial Overview9.3.1.4. Business Strategies and Development9.3.2. Amt Medical SRL9.3.2.1. Company Overview9.3.2.2. Therapy Portfolio9.3.2.3. Financial Overview9.3.2.4. Business Strategies and Development9.3.3. Ivoclar Vivadent9.3.3.1. Company Overview9.3.3.2. Therapy Portfolio9.3.3.3. Financial Overview9.3.3.4. Business Strategies and Development9.3.4. VITA Zahnfabrik H. Rauter GmbH & Co. KG.9.3.4.1. Company Overview9.3.4.2. Therapy Portfolio9.3.4.3. Financial Overview9.3.4.4. Business Strategies and Development9.3.5. Merz Dental GmbH9.3.5.1. Company Overview9.3.5.2. Therapy Portfolio9.3.5.3. Financial Overview9.3.5.4. Business Strategies and Development9.3.6. 3D Diagnostix Inc.9.3.6.1. Company Overview9.3.6.2. Therapy Portfolio9.3.6.3. Financial Overview9.3.6.4. Business Strategies and Development9.3.7. Medical Precision Implants9.3.7.1. Company Overview9.3.7.2. Therapy Portfolio9.3.7.3. Financial Overview9.3.7.4. Business Strategies and Development9.3.8. FSM Dental Medikal Mak. San. Tic. Ltd9.3.8.1. Company Overview9.3.8.2. Therapy Portfolio9.3.8.3. Financial Overview9.3.8.4. Business Strategies and Development9.3.9. Yamahachi Dental Mfg Co.9.3.9.1. Company Overview9.3.9.2. Therapy Portfolio9.3.9.3. Financial Overview9.3.9.4. Business Strategies and Development9.3.10. Others9.3.10.1. Company Overview9.3.10.2. Therapy Portfolio9.3.10.3. Financial Overview9.3.10.4. Business Strategies and Development9.3.11. Others9.3.11.1. Company Overview9.3.11.2. Therapy Portfolio9.3.11.3. Financial Overview9.3.11.4. Business Strategies and Development10. Appendix10.1. Research Methodology10.2. Report Assumptions10.3. Acronyms and Abbreviations Companies Featured Polident D.O.O. Amt Medical SRL Ivoclar Vivadent VITA Zahnfabrik H. Rauter GmbH & Co. KG. Merz Dental GmbH 3D Diagnostix Inc. Medical Precision Implants FSM Dental Medikal Mak. San. Tic. Ltd. Yamahachi Dental Mfg Co. For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
01-05-2025
- Business
- Yahoo
Straumann Holding AG (SAUHF) Q1 2025 Earnings Call Highlights: Strong Organic Growth Amid ...
Revenue: CHF681 million, reflecting an organic growth of 11%. Core EBIT Margin: Expected improvement of 30 to 60 basis points at constant 2024 currency rates. Dividend: Increased by 12% compared to the previous year. Regional Performance: Strong double-digit growth in EMEA, APAC, and Latin America; positive growth in North America despite soft demand. Product Segments: Significant growth across implantology, orthodontics, and digital solutions. Market Share: Approximately 12.5% in the global market, with 35% in implantology. Manufacturing Expansion: 19 production facilities worldwide, with new sites in Shanghai and Curitiba under development. Warning! GuruFocus has detected 6 Warning Sign with BCS. Release Date: April 30, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Straumann Holding AG (SAUHF) reported strong organic revenue growth of 11% in Q1 2025, reaching CHF681 million. The company saw significant performance in the EMEA and APAC regions, with double-digit growth in emerging markets like Thailand, India, and Malaysia. Straumann's collaboration with SprintRay and the launch of the Straumann Access platform mark significant advancements in digital dentistry. The company's multi-brand and multi-price strategy has been effective in gaining market share across different customer segments. Straumann is investing in expanding its manufacturing footprint, with new facilities in China and Brazil to support growth and supply chain resilience. The macroeconomic environment remains uncertain, impacting consumer sentiment and leading to soft demand in North America. Foreign exchange headwinds could pose challenges in the coming quarters due to the strengthening of the CHF. The orthodontics business in North America remains soft, affecting overall regional performance. Tariffs and geopolitical complexities could impact financials, although measures are in place to mitigate these effects. The company faces competitive pressures in the US market, with price competition remaining high. Q: Can you elaborate on the guidance for 2025, considering the strong start to the year and the macroeconomic uncertainties? A: Guillaume Daniellot, CEO: We are pleased with our first quarter performance. Despite the uncertainties, we believe that achieving high-single digit growth is a significant objective. The macroeconomic environment remains unpredictable, so we are cautious. If conditions remain favorable, we may revise our guidance later in the year. Q: Which new products do you expect to drive growth in the next 12 to 24 months? A: Guillaume Daniellot, CEO: The iEXCEL implant system is expected to grow our market share in the premium segment. Our digital solutions, particularly the scanner portfolio, are gaining traction in markets like Brazil and China. Additionally, our partnership with SprintRay for chairside 3D printing could significantly impact single-visit restorations. Q: Are you seeing any softness in the US or Europe due to macroeconomic headwinds? A: Guillaume Daniellot, CEO: In North America, we observed volatility rather than a consistent decline. The market is reacting to macroeconomic news, but we ended the quarter stronger than expected. We anticipate a more stable environment in the coming months. Q: What are the expected foreign exchange and tariff impacts for the rest of the year? A: Xu Yang, CFO: We saw minimal foreign exchange impact in Q1, but future headwinds could be around 100 basis points on the top line. Tariffs are embedded in our guidance, and our global network helps mitigate their impact, though we are not immune. Q: How is the US market expected to perform in 2025 compared to 2024? A: Guillaume Daniellot, CEO: Despite unpredictability, we expect 2025 to outperform 2024. We have strong fundamentals, including innovation and market share gains, which should support growth even in a challenging macro environment. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Sign in to access your portfolio
Reuters
19-02-2025
- Business
- Reuters
Dental implant maker Straumann expects China demand to lift 2025 growth
Feb 19 (Reuters) - Swiss dental implant maker Straumann Holding (STMN.S), opens new tab expects rising demand from China to help boost sales growth this year, it said on Wednesday after reporting 2024 revenues that matched market estimates. Straumann, which specialises in tooth replacement and orthodontic solutions, said Asia-Pacific sales grew 33% in 2024, helped by China's initiative to reduce the price of medicines as part of a new procurement policy, and increased market share. Under China's new volume-based procurement model, implant prices for end customers have fallen sharply, boosting demand in the country. "The whole 2025, we believe, will still be beneficial for the patient flow remaining dynamic because what has been unlocked as a patient pool is really massive," CEO Guillaume Daniellot told Reuters. He said the company was in a strong position to grow in China this year. Asia-Pacific accounts for more than a fifth of the company's sales. The group reported 13.7% organic revenue growth to 2.5 billion francs ($2.77 billion) last year, roughly in line with analysts' average forecast of 2.49 billion francs in a poll compiled by Vara Research. It's shares were lower in early trade by later recovered and were up 2.7% at 1133 GMT. Straumann expects overall sales growth in 2025 to be in the high single-digit percentage range, with the margin on earnings before interest and taxes (EBIT) for the year seen improving by 30 to 60 basis points at constant currency rates. Its core EBIT margin came in at 26% in 2024, slightly below the consensus expectation of 26.5%. Full year core net profit rose to 502 million Swiss francs ($556 million) from 482 million francs the previous year. But Straumann's North America business, which makes up 28% of its revenue, grew just 3.6% organically in 2024 although Daniellot pointed to signs of improvement. "We are seeing some light increase in patient traffic since the end of the election period in the U.S. ... and then we hope to have sequential improvement quarter by quarter," he said. ($1 = 0.9033 Swiss francs)
